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The expression of T-cell-associated serine proteinase 1 (MTSP-1) in vivo during Leishmania major infection
was analyzed in genetically resistant C57BL/6 mice and in genetically susceptible BALB/c mice. Using a
monoclonal antibody as well as an RNA probe specific for MTSP-1 to stain tissue sections, we found T cells
expressing MTSP-1 in skin lesions and spleens of mice of both strains. In skin lesions, MTSP-1-positive T cells
could be detected as early as 3 days after infection. Most importantly, the frequency of T cells expressing
MTSP-1 was significantly higher in susceptible BALB/c mice than in resistant C57BL/6 mice. These findings
suggest that MTSP-1 is associated with disease-promoting T cells and that it may be an effector molecule
involved in the pathogenesis of cutaneous leishmaniasis.
Protozoan parasites of the genus Leishmania cause a
spectrum of human diseases ranging from self-healing cuta-
neous ulcers to fatal visceral dissemination, depending on
both the host's immune response and the species of parasite.
The distinct disease patterns can be reproduced experimen-
tally in mice. After infection with Leishmania major, the
cause of cutaneous leishmaniasis, mice of genetically resis-
tant inbred strains (e.g., C57BL/6) can contain the infection
with cutaneous lesions healing spontaneously, whereas ge-
netically susceptible mice (e.g., BALB/c) develop progres-
sive cutaneous ulceration and visceralization and eventually
die. It has been shown that both resistance and susceptibility
to disease are elicited by the CD4+ T-cell subpopulation (10,
16).
Previous studies have shown that T effector cells synthe-
size a variety of soluble mediators, such as lymphokines and
enzymes, which are secreted upon antigenic stimulation (25,
26). Among other proteins, cytoplasmic granules of acti-
vated T cells contain a serine proteinase (20), termed syn-
onymously murine T-cell-associated serine proteinase 1
(MTSP-1; 22), granzyme A (12), serine esterase 1 (27), and
Hanukah factor (5), which is produced in vitro by all CD8+
and a fraction of CD4+ T cells (4). The cDNA for this
enzyme has been cloned (5). In vivo, MTSP-1 has been
demonstrated in T cells previously sensitized during viral
infections (8, 18), allograft rejection (17), or autoimmune
diseases (19).
Preliminary studies on the possible function of MTSP-1
indicated that the enzyme might be involved in T-cell-
mediated processes, such as the control of virus replication
(8, 18), extravasation (24), and inflammation (1). In the
present study on the potential involvement of MTSP-1 in the
pathology of murine cutaneous leishmaniasis, we analyzed
the expression of MTSP-1 in infected mice by both immu-
nocytochemistry and in situ hybridization with RNA probes.
The cloned virulent parasite isolate used for this study was
confirmed to be L. major by isoenzyme analysis (D. Evans,
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London School of Hygiene and Tropical Medicine, London,
England) and was maintained by passage in BALB/c mice.
Promastigotes were grown in vitro in blood agar cultures.
Stationary-phase promastigotes (2 x 106) were injected in a
volume of 50 ,ul intradermally on the dorsum of the mouse
close to the base of the tail. Female mice of the inbred strains
BALB/c and C57BL/6 were purchased from Charles River
Wiga Breeding Laboratories (Sulzfeld, Federal Republic of
Germany). Lesion scores were determined according to the
following system: 0 = no lesion; 1 = small swelling (up to 5
mm in average diameter); 2 = large swelling (more than 5
mm in average diameter) or open lesion of less than 5 mm in
average diameter; 3 = open lesion of more than 5 mm in
average diameter.
For immunohistological analysis of MTSP-1 expression,
frozen sections (4 p.m) of organs from infected mice were
stained with a rat monoclonal antibody recognizing MTSP-1
(8). Monoclonal rat anti-mouse CD4 and CD8 antibodies
were derived from the hybridomas H129.19 (21) and 53-6.7
(9), respectively. A three-step streptavidin-biotin-peroxidase
(ABC) method was used as previously described (8). The
preparation of 35S-labeled RNA probes of the MTSP-1 gene
(Hanukah factor gene [5]) and the in situ hybridization of
cryostat sections were done as previously described in detail
(17, 18). Multiple sections from each tissue were hybridized
with either an antisense RNA probe or a sense RNA probe,
the latter as a nonhybridizing control which uniformly gave
negative results. Spleens from mice infected with lympho-
cytic choriomeningitis virus, known to be positive for
expression of MTSP-1 (8, 18), and tissues from uninfected
mice were included in each experiment as a positive and
negative control, respectively.
C57BL/6 and BALB/c mice were infected intradermally
with L. major, and at different time intervals thereafter,
lesional skin, draining lymph nodes, and spleens were re-
moved and analyzed by immunocytochemistry. Figure 1
illustrates the course of cutaneous lesion development in the
two strains of mice. In the initial series of experiments, we
analyzed the distribution of CD4+ and CD8+ T cells. At any
time of infection tested, the distribution pattern as well as
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the ratio of CD4+ to CD8' T cells in sections of spleens and
lymph nodes were comparable to those of uninfected control
mice (data not shown). Analysis of the lesional skin, how-
ever, revealed that on day 3 after infection, T cells infil-
trating the lower dermal compartment were exclusively of
the CD4+ phenotype. This was found for mice of both
strains, the number of CD4+ cells being significantly higher
in BALB/c mice (Fig. 2A) than in C57BL/6 mice (Fig. 2B).
No CD8+ T cells were observed at this time point (as shown
for BALB/c in Fig. 2C). At later stages of disease, the
number of CD8+ cells in the lesions increased, particularly
in C57BL/6 mice, but remained consistently lower than that
of CD4+ cells (Table 1).
1 0 20 30 40 In skin lesions of susceptible BALB/c mice, numerous T
cells expressing MTSP-1 could be detected by immunostain-
Time after infection (days) ing as early as 3 days after infection (Fig. 2D), at a time when
ofctaneouinfectioni su e a all the infiltrating lymphocytes were shown to be of the
c (c) andCe7BL/6(i)n incsusceptible and CD4+ phenotype (Table 1; Fig. 2A and C). MTSP-1 expres-
X 106 L. major promastigotes. Arithmetic sion was strongest in the early phase of infection, before the
lesion scores and standard errors are given appearance of open lesions (at approximately 3 weeks after
infection). In resistant C57BL/6 mice, on the other hand, the
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FIG. 2. Immunohistochemical analysis of tissue sections from mice infected with L. major (ABC method, hematoxylin counterstaining).
CD4+ cells are abundant in lesional skin of BALB/c mice (A) and are much less frequent in C57BL/6 mice (B) on day 3 after infection. As
demonstrated in panel C for BALB/c mice, no CD8+ cells can be detected in this organ at the same time point. High levels of MTSP-1
expression are found in the cutaneous lesions (D and E; day 3) and the spleens (F and H; day 14) of BALB/c mice. MTSP-1-positive cells
can also be detected in the spleens of C57BL/6 mice (G; day 14), but their percentage is markedly lower. Scale bars: A, C, D, F, and G, 90
,m; B, 70 ,um; E, 10 ,um; H, 20 iLm.
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TABLE 1. Expression of T-cell surface markers CD4 and CD8 in
cutaneous lesions of L. major-infected micea
Antigen detected at the following day after infection'
Mouse 3 7 14 21
strain
CD4 CD8 CD4 CD8 CD4 CD8 CD4 CD8
C57BL/6 + - ++ + +++ ++ ++ +
BALB/c ++ - +++ + +++ + ++ +
a Immunohistochemistry was performed as described previously (8). The
results represent means of two experiments with two mice for each time point,
respectively.
-, negative (comparable to Fig. 1C); +, less than 5% positive cells in
scattered distribution (comparable to Fig. 1B); + +, 5% to 20% positive cells
(comparable to Fig. 1A); +++, more than 20% positive cells.
number of T cells expressing MTSP-1 remained markedly
lower (Table 2).
To investigate whether the high levels of MTSP-1 protein
expression in L. major-infected BALB/c mice were due to
transcriptional or translational regulation, we performed in
situ hybridization experiments using RNA probes of the
MTSP-1 gene. In lesional skin, a high number of cells
displayed strong hybridization signals as demonstrated by
the dense cell-associated silver grain accumulation (day 14
after infection; Fig. 3A and B). In contrast, MTSP-1 mRNA
expression could not be detected in infected C57BL/6 mice
(Fig. 3C) despite the abundance of infiltrating lymphocytes.
T cells expressing MTSP-1 were also detected by immu-
nostaining of spleen sections from mice infected with L.
major (Table 2). As for skin lesions, the number of splenic T
cells expressing MTSP-1 was significantly higher in suscep-
tible BALB/c mice than in resistant C57BL/6 mice. This
difference was most pronounced on day 14 after infection
(Fig. 2F and G). In spleens (Fig. 2H) and in cutaneous
lesions (Fig. 2E), MTSP-1 was confined to intracellular
granular structures of T cells. Only few MTSP-1+ T cells
were detected in lymph nodes draining the lesions (data not
shown). Cells expressing MTSP-1 were absent in sections of
the spleen and skin from uninfected mice (Table 2).
The present study suggests the involvement of the proteo-
lytic enzyme MTSP-1 in the pathogenesis of L. major
infection in mice. In the course of cutaneous disease, the
frequency of T cells expressing MTSP-1 was much higher in
spleens and skin lesions of susceptible BALB/c mice than in
those of resistant C57BL/6 mice. This significant difference
TABLE 2. Expression of MTSP-1 in L. major-infected micea
Expression at the following day
Source after infectionb:
0 3 7 14 21 28
Skin/cutaneous lesion
C57BL/6 - - + + + +
BALB/c - ++ ++ ++ + +
Spleen
C57BL/6 - + + + + +
BALB/c - + + + t+ ++ +
a Immunohistochemistry was performed as described previously (8). The
results represent means of two experiments with two mice for each time point,
respectively.
b, negative (comparable to Fig. 1C for cutaneous lesion); +, less than 5%
positive cells in scattered distribution (comparable to Fig. 1G for spleen); + +,
5 to 20% positive cells (comparable to Fig. 1D for cutaneous lesion); + ++,
more than 20% positive cells (comparable to Fig. 1F for spleen).
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FIG. 3. In situ hybridization for detection of MTSP-1 mRNA in
skin lesions at 2 weeks after infection with L. major. The bright-field
photomicrograph shows a skin section of a BALB/c mouse (A) with
a high percentage of MTSP-1 gene-expressing cells which are easily
seen by epipolarization illumination (B). No MTSP-1 mRNA-posi-
tive cells were detectable in C57BL/6 mice (C; combination of
bright-field and epipolarization illumination). Scale bars = 25 ,um.
was demonstrated on the translational level by using an
antibody specific for the MTSP-1 protein as well as on the
transcriptional level by using radiolabeled probes that detect
MTSP-1 mRNA. Staining of sequential sections and deter-
mination of the enzyme activity of purified lymphocytes in
vitro confirmed that MTSP-1 expression in infected mice
was associated with T cells (data not shown). Thus, it is
tempting to speculate that in murine L. major infection,
MTSP-1 is associated with disease-promoting rather than
resistance-promoting T cells. In accordance with this as-
sumption is the interesting observation that MTSP-1 expres-
sion was also enhanced in an unusually severe skin lesion of
an individual C57BL/6 mouse with no sign of healing at day
35 after infection (data not shown). We have previously
demonstrated that C57BL/6 mice presenting with such an
unusual course of disease have an increased frequency of
disease-promoting T cells (14). This finding emphasizes that
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MTSP-1 expression in infected C57BL/6 mice is not gener-
ally decreased but is related to the severity of cutaneous
leishmaniasis. During the immune response to another infec-
tious agent, lymphocytic choriomeningitis virus, T cells from
C57BL/6 mice also express high levels of MTSP-1 (8, 18).
It is of interest that we consistently detected only a few
MTSP-1-expressing T cells in the lymph nodes draining the
lesions of BALB/c mice. At present, the significance of this
finding is unclear. It is possible that this small population of
MTSP-1+ cells contains a particularly high proportion of L.
major-specific lymphocytes and/or that MTSP-1 is expressed
only after migration of L. major-reactive T cells from the
lymph nodes to the cutaneous lesion.
Previous studies have shown that MTSP-1 is mainly
associated with cytolytic CD8+ T cells in vitro (12, 20, 22,
27) and in vivo (8) and that only a fraction of murine (4) or
human (11) CD4+ T cells express MTSP-1 in vitro. Our own
findings in mice (3) and a recent report by Cooper et al. (2) on
T-cell subsets in human leprosy lesions strongly suggested
the existence of CD4+ T cells expressing MTSP-1 or its
human analog in vivo. In the present study, high numbers of
T cells expressing MTSP-1 were observed in L. major-
infected skin sections that did not display CD8+ cells.
Moreover, the location of these MTSP-1-containing cells
was identical to that of CD4+ cells. These findings under-
score the capacity of both T-cell subsets, CD8+ and CD4+,
to express MTSP-1 in vivo.
Our immunohistological examinations of L. major-in-
fected skin consistently demonstrated the presence of T cells
not only in lesions of C57BL/6 mice but also in those of
BALB/c mice. On the other hand, a previous report (13)
showed that the T-cell influx into the infected dermis of
BALB/c mice is minimal. This discrepancy may be ex-
plained by the use of a different parasite strain, L. mexicana
amazonensis, in the latter study because, even in self-
healing C57BL/6 mice, cutaneous L. mexicana amazonensis
infection is associated with a overall delayed T-cell response
in the skin lesion (13). In accordance with McElrath et al.
(13), we found that the ratio of CD4+ to CD8+ T cells in
spleen and lymph node sections did not change during
infection for either strain of mice, although the absolute
number of T cells increased in amounts proportional to the
overall enlargement of these organs. However, on the basis
of tissue sections, it is difficult to estimate the total number
of T cells per organ, and this may be the reason why others
(7), after labeling of isolated cell suspensions, have found
different population dynamics during infection.
Analysis of the time course of MTSP-1 expression re-
vealed that T cells containing the enzyme were detectable as
early as 3 days after infection. Together with the fact that the
number of lymphocytes expressing MTSP-1 decreased at
later stages of chronic disease, this implies that MTSP-1 is
involved in early events leading to the development of
cutaneous lesions. Our recent finding that MTSP-1 is able to
cleave structural molecules of the extracellular matrix, such
as fibronectin (23), collagen type IV (24a), and sulfated
proteoglycans (24), suggests that this proteolytic enzyme
directly contributes to tissue destruction and development of
ulcerative lesions. Proteolytic degradation of extracellular
matrix proteins may furthermore facilitate recruitment of
other cell populations required for subsequent completion of
lesion formation. These effects may even be enhanced by
MTSP-1-mediated activation of the plasminogen activator/
plasmin system (1), a potent system of extracellular proteo-
lysis. Future studies will be addressed to the possible
involvement of MTSP-1 in pathophysiological processes,
including ulcerative inflammation.
The present data indicate that disease-promoting CD4+
cells may differ from resistance-promoting CD4+ cells not
only in the pattern of lymphokine production (6, 15) but also
in the expression of the proteolytic enzyme MTSP-1. It will
now be of interest to determine the frequency and antigen
specificity of CD4+ MTSP-1+ T cells from L. major-infected
mice and to study their functional capacity including the
pattern of lymphokine production. Current work is focused
on this aspect.
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